| FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma P Lohmann, P Stavrinou, K Lipke, EK Bauer, G Ceccon, JM Werner, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-12, 2018 | 21 | 2018 |
| Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression N Galldiks, M Kocher, G Ceccon, JM Werner, A Brunn, M Deckert, ... Neuro-oncology 22 (1), 17-30, 2020 | 20 | 2020 |
| Discordance and conversion rates of progesterone-, estrogen-, and HER2/neu-receptor status in primary breast cancer and brain metastasis mainly triggered by hormone therapy M Timmer, JM Werner, G Roehn, M Ortmann, T Blau, C Cramer, ... Anticancer research 37 (9), 4859-4865, 2017 | 20 | 2017 |
| Dabrafenib treatment in a patient with an epithelioid glioblastoma and BRAF V600E mutation G Ceccon, JM Werner, V Dunkl, C Tscherpel, G Stoffels, A Brunn, ... International journal of molecular sciences 19 (4), 1090, 2018 | 19 | 2018 |
| Combined amino acid positron emission tomography and advanced magnetic resonance imaging in glioma patients P Lohmann, JM Werner, NJ Shah, GR Fink, KJ Langen, N Galldiks Cancers 11 (2), 153, 2019 | 17 | 2019 |
| Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI JM Werner, G Stoffels, T Lichtenstein, J Borggrefe, P Lohmann, G Ceccon, ... European journal of nuclear medicine and molecular imaging 46 (9), 1889-1901, 2019 | 15 | 2019 |
| Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma JM Werner, V Schweinsberg, M Schroeter, B von Reutern, MP Malter, ... Frontiers in Oncology 9, 84, 2019 | 13 | 2019 |
| Current landscape and emerging fields of pet imaging in patients with brain tumors JM Werner, P Lohmann, GR Fink, KJ Langen, N Galldiks Molecules 25 (6), 1471, 2020 | 7 | 2020 |
| Treatment Monitoring of Immunotherapy and Targeted Therapy using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences N Galldiks, DSY Abdulla, M Scheffler, F Wolpert, JM Werner, MW Huellner, ... Journal of Nuclear Medicine, jnumed. 120.248278, 2020 | 6 | 2020 |
| Simulation-based training of the rapid evaluation and management of acute stroke (STREAM)—a prospective single-arm multicenter trial FO Bohmann, N Kurka, R Du Mesnil de Rochemont, K Gruber, J Guenther, ... Frontiers in neurology 10, 969, 2019 | 5 | 2019 |
| Flare Phenomenon in O-(2-18F-Fluoroethyl)-l-Tyrosine PET After Resection of Gliomas CP Filss, AK Schmitz, G Stoffels, C Stegmayr, P Lohmann, JM Werner, ... Journal of Nuclear Medicine 61 (9), 1294-1299, 2020 | 4 | 2020 |
| Expression of FAS-L differs from primary to relapsed low-grade gliomas and predicts progression-free survival JM Werner, S Kuhl, P Stavrinou, G Roehn, B Krischek, T Blau, ... Anticancer research 37 (12), 6639-6648, 2017 | 4 | 2017 |
| Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors N Galldiks, P Lohmann, JM Werner, G Ceccon, GR Fink, KJ Langen Expert review of anticancer therapy 20 (1), 9-15, 2020 | 3 | 2020 |
| Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI N Galldiks, JM Werner, C Tscherpel, GR Fink, KJ Langen Neuro-oncology advances 1 (1), vdz038, 2019 | 3 | 2019 |
| Feature-based PET/MRI radiomics in patients with brain tumors P Lohmann, AK Meißner, M Kocher, EK Bauer, JM Werner, GR Fink, ... Neuro-oncology advances 2 (Supplement_4), iv15-iv21, 2020 | 2 | 2020 |
| FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ... Cancers 12 (12), 3835, 2020 | 2 | 2020 |
| Expression of CD40 correlates negatively with overall and progression-free survival of low-and high-grade gliomas JM Werner, S Kuhl, K Ulrich, B Krischek, P Stavrinou, R Goldbrunner, ... World neurosurgery 130, e17-e25, 2019 | 2 | 2019 |
| OS9. 6 diagnosis of pseudoprogression using FET PET radiomics P Lohmann, MA Elahmadawy, J Werner, M Rapp, G Ceccon, GR Fink, ... Neuro-oncology 21 (Suppl 3), iii19, 2019 | 2 | 2019 |
| Death receptor 6 (DR6) Is overexpressed in astrocytomas S Stegmann, JM Werner, S Kuhl, G Roehn, B Krischek, P Stavrinou, ... Anticancer research 39 (5), 2299-2306, 2019 | 2 | 2019 |
| Early treatment response assessment using 18F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy G Ceccon, P Lohmann, JM Werner, C Tscherpel, V Dunkl, G Stoffels, ... Journal of Nuclear Medicine, jnumed. 120.254243, 2020 | 1 | 2020 |
Gereon R. FinkProfessor of Neurology, University Hospital Cologne & Research Centre JülichDirección de correo verificada de fz-juelich.de
